细胞衰老在神经退行性疾病中的作用
Yating Wang1, Kamil Kuca2,3,4, Li You5
1College of Life Science, Yangtze University, Jingzhou, 434025, China.
Archives of toxicology
|May 14, 2024
概括
细胞衰老,标志着特定蛋白质表达和分泌,驱动神经退行性疾病 (NDs). 向衰老细胞及其有害分泌物为阿尔茨海默氏症和帕金森病等疾病提供了一个有希望的治疗策略.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 细胞衰老越来越多地与神经退行性疾病 (NDs) 的病原发生有关,包括阿尔茨海默氏症和帕金森病.
- 衰老细胞释放与衰老相关的分泌表型 (SASP),可以损害神经细胞,如微质细胞.
- 在ND模型中观察到衰老的标志,包括p16,p21表达和升高的β-galactosidase活性,并导致标志性病理.
研究的目的:
- 阐明细胞衰老有助于神经退行性疾病病原的机制.
- 审查目前针对衰老细胞及其相关途径的策略,以获得ND的治疗益处.
主要方法:
- 关于细胞衰老和神经退行现有文献的综述.
- 分析SASP组件 (例如,MMP-3,IL-1α,IL-6,IL-8) 在神经损伤中的作用.
- 在ND模型中调查衰老特征 (p16,p21,β-galactosidase).
- 针对衰老细胞和信号通路的治疗干预措施的检查 (p38/MAPK,NF-κB).
- 评估端粒缩短作为生物标志物及其与衰老引起的炎症的联系.
主要成果:
- 细胞衰老和SASP有助于β-粉样蛋白和tau病理.
- 在AD模型中,抑制p38/MAPK和NF-κB信号通路,以及衰老细胞清除,减少病理并改善认知.
- 端粒功能障碍会诱导衰老和炎症性细胞因子的释放 (IL-6,TNF-α,IL-1β).
- 端粒酶激活可以防止衰老,并产生神经保护作用.
结论:
- 细胞衰老是神经退行性疾病病理学的重要驱动因素.
- 向衰老细胞,调节SASP和激活端粒酶代表了ND的可行的治疗策略.
- 对老化疗法和端粒维护的进一步研究对治疗阿尔茨海默病,帕金森病和相关疾病充满希望.
相关概念视频
Aging
49
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Mitochondria
12.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
12.3K
Neurogenesis and Regeneration of Nervous Tissue
765
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
765
Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533
Overview of Cell Death
7.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.2K


